Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151239 · ClinicalTrials.gov registry record · NA
Effect of "Nicotinamide Mononucleotide" (NMN) on Cardiometabolic Function
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03151239 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 25 participants.
The verdict
NCT03151239, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of the study is to understand the effect of the dietary supplement "Nicotinamide mononucleotide" on metabolic health in people.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT NMN supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03151239
The ClinicalTrials.gov registry entry for NCT03151239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03151239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03151239 about?
NCT03151239 is a clinical study titled "Effect of "Nicotinamide Mononucleotide" (NMN) on Cardiometabolic Function". The purpose of the study is to understand the effect of the dietary supplement "Nicotinamide mononucleotide" on metabolic health in people.
What is the current status of trial NCT03151239?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-07-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03151239?
The interventions under investigation include: Placebo (OTHER), NMN supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03151239?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.